Dec 02 2024 34 mins 5
In this InTechnology episode, Camille Morhardt discusses the application of artificial intelligence (AI) in the biopharmaceutical and life sciences sectors with Prashant Shah, Intel's CTO for federated artificial intelligence products, and Abhishek Pandey, a global lead and principal research scientist at AbbVie. The conversation centers on the potential of AI, particularly federated learning, to revolutionize drug discovery and development. They explore the challenges of data privacy and IP protection in this context, emphasizing the importance of collaboration and the role of initiatives like OpenFL and MLCommons in setting standards for AI in the industry.
The views and opinions expressed are those of the guests and author and do not necessarily reflect the official policy or position of Intel Corporation.
